12:00 AM
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Repository corticotropin injection regulatory update

Questcor said FDA does not expect to meet the Sept. 11 PDUFA date for an sNDA for H.P. Acthar Gel to treat infantile spasms. The company said FDA requires more time to finalize...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >